Jim Cramer on Danaher Corporation (DHR): From Best to Worst Amid China Struggles
Live Cell Imaging Market Worth US$4.75 Billion in 2030 With 8.68% CAGR | MarketsandMarkets
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
Market Whales and Their Recent Bets on DHR Options
Should You Investigate Danaher Corporation (NYSE:DHR) At US$197?
New Analyst Forecast: $DHR Given $240.0 Price Target
Express News | Danaher Corporation : HSBC Cuts Target Price to $240 From $270
Scotiabank Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $265
Express News | Form 144 | Danaher(DHR.US) Insider Proposes to Sell 117.56 Million in Common Stocks
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
How Is The Market Feeling About Danaher?
A Quick Look at Today's Ratings for Danaher(DHR.US), With a Forecast Between $210 to $265
Analyst Sees Opportunity In Danaher Stock As Sentiment Improves
Express News | RBC Capital Reiterates Outperform on Danaher, Maintains $250 Price Target
Express News | Goldman Sachs Maintains Buy on Danaher, Lowers Price Target to $240
Danaher Corporation (DHR): Among Top Stocks in Bill Gates' Portfolio With Huge Upside Potential
Danaher Price Target Maintained With a $250.00/Share by Guggenheim
Stifel Nicolaus Reaffirms Their Buy Rating on Danaher (DHR)
Danaher Is Maintained at Buy by UBS
Express News | Danaher Corp : UBS Cuts Target Price to $240 From $275